Drake CG - Search Results

1

Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome.

GuhaThakurta D, Sheikh NA, Fan LQ, Kandadi H, Meagher TC, Hall SJ, Kantoff PW, Higano CS, Small EJ, Gardner TA, Bailey K, Vu T, DeVries T, Whitmore JB, Frohlich MW, Trager JB, Drake CG. GuhaThakurta D, et al. Among authors: drake cg. Clin Cancer Res. 2015 Aug 15;21(16):3619-30. doi: 10.1158/1078-0432.CCR-14-2334. Epub 2015 Feb 3. Clin Cancer Res. 2015. PMID: 25649018 Free PMC article. Clinical Trial.

2

Eleventh Prouts Neck Meeting on Prostate Cancer: emerging strategies in prostate cancer therapy.

Keller ET, Rowley DR, Tomlins SA, Drake CG, Kantoff PW, Pienta KJ, Montie JE, Carter HB, Hruszkewicz AM, Gomez J, Mohla S, Getzenberg RH. Keller ET, et al. Among authors: drake cg. Cancer Res. 2007 Oct 15;67(20):9613-5. doi: 10.1158/0008-5472.CAN-07-1529. Epub 2007 Oct 10. Cancer Res. 2007. PMID: 17928375 No abstract available.

3

Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model.

Wada S, Yoshimura K, Hipkiss EL, Harris TJ, Yen HR, Goldberg MV, Grosso JF, Getnet D, Demarzo AM, Netto GJ, Anders R, Pardoll DM, Drake CG. Wada S, et al. Among authors: drake cg. Cancer Res. 2009 May 15;69(10):4309-18. doi: 10.1158/0008-5472.CAN-08-4102. Epub 2009 May 12. Cancer Res. 2009. PMID: 19435909 Free PMC article.

4

Immunotherapy for prostate cancer: an emerging treatment modality.

Drake CG. Drake CG. Urol Clin North Am. 2010 Feb;37(1):121-9, Table of Contents. doi: 10.1016/j.ucl.2009.11.001. Urol Clin North Am. 2010. PMID: 20152525 Free PMC article. Review.

5

Update: immunological strategies for prostate cancer.

Drake CG, Antonarakis ES. Drake CG, et al. Curr Urol Rep. 2010 May;11(3):202-7. doi: 10.1007/s11934-010-0106-8. Curr Urol Rep. 2010. PMID: 20425628 Free PMC article. Review.

6

Prostate cancer as a model for tumour immunotherapy.

Drake CG. Drake CG. Nat Rev Immunol. 2010 Aug;10(8):580-93. doi: 10.1038/nri2817. Nat Rev Immunol. 2010. PMID: 20651745 Free PMC article. Review.

7

Lenalidomide in nonmetastatic biochemically relapsed prostate cancer: results of a phase I/II double-blinded, randomized study.

Keizman D, Zahurak M, Sinibaldi V, Carducci M, Denmeade S, Drake C, Pili R, Antonarakis ES, Hudock S, Eisenberger M. Keizman D, et al. Clin Cancer Res. 2010 Nov 1;16(21):5269-76. doi: 10.1158/1078-0432.CCR-10-1928. Epub 2010 Oct 26. Clin Cancer Res. 2010. PMID: 20978144 Free PMC article. Clinical Trial.

8

Immunotherapy for prostate cancer: recent advances, lessons learned, and areas for further research.

Gulley JL, Drake CG. Gulley JL, et al. Among authors: drake cg. Clin Cancer Res. 2011 Jun 15;17(12):3884-91. doi: 10.1158/1078-0432.CCR-10-2656. Clin Cancer Res. 2011. PMID: 21680544 Free PMC article. Review.

9

Prostate cancer immunotherapy.

May KF Jr, Gulley JL, Drake CG, Dranoff G, Kantoff PW. May KF Jr, et al. Among authors: drake cg. Clin Cancer Res. 2011 Aug 15;17(16):5233-8. doi: 10.1158/1078-0432.CCR-10-3402. Epub 2011 Jun 23. Clin Cancer Res. 2011. PMID: 21700764 Free PMC article.

10

Ipilimumab: an anti-CTLA-4 antibody for metastatic melanoma.

Lipson EJ, Drake CG. Lipson EJ, et al. Among authors: drake cg. Clin Cancer Res. 2011 Nov 15;17(22):6958-62. doi: 10.1158/1078-0432.CCR-11-1595. Epub 2011 Sep 7. Clin Cancer Res. 2011. PMID: 21900389 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

418 results

Search Page

Filters